| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2024 | Mar 20, 2024 | Ovid Therapeutics Inc. | CEO | Buy | 72.5 | +18,248 | 0.50% | ✗ | $50.4K |
| Aug 28, 2020 | Sep 1, 2020 | Ovid Therapeutics Inc. | CEO | Buy | 56.3 | +8,488 | 0.15% | ✗ | $49.6K |
| Oct 8, 2019 | Oct 10, 2019 | Ovid Therapeutics Inc. | CEO | Buy | 82.5 | +60,000 | 1.16% | ✗ | $150K |
| Feb 22, 2019 | Feb 26, 2019 | Ovid Therapeutics Inc. | CEO | Buy | 82.5 | +75,000 | 1.47% | ✗ | $150K |
| Aug 25, 2017 | Aug 28, 2017 | Ovid Therapeutics Inc. | CEO | Buy | 65.0 | +15,334 | 0.30% | ✗ | $109.6K |